
Sagility India IPO
- Issue price
- ₹30
- Listing price
- ₹31.06
- +3.53%
- Current price
- ₹43.87
- +46.23%
- Subscribed
- 3.2x
- Issue size
- ₹2,106.4 Cr
- Listed on
- 12 Nov 2024
IPO timeline
- Opens5 NovTue
- Closes7 NovThu
- Allotment8 NovFri
- Refunds8 NovFri
- Demat credit11 NovMon
- Listing12 NovTue
Issue details
- Price band
- ₹28 – ₹30 per share
- Issue size
- ₹2,106.4 Cr
- Fresh issue
- None
- Offer for sale
- ₹2,106.4 Cr
- Issue type
- OFS only
- Face value
- ₹10 per share
- Lot size
- 500 shares
- Minimum investment
- ₹15,000
- Listing on
- BSE, NSE
- Exchange code
- SAGILITY · 544282
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 500 | ₹15,000 |
| Retail (Max) | 13 | 6,500 | ₹1,95,000 |
| S-HNI (Min) | 14 | 7,000 | ₹2,10,000 |
| B-HNI (Min) | 67 | 33,500 | ₹10,05,000 |
Reservation
- QIB
- 52,52,24,447 shares (75.00% of the Offer)
- NII
- 10,50,44,889 shares (15.00% of the Offer)
- Retail
- 7,00,29,926 shares (10.00% of the Offer)
- Employee
- 19,00,000 shares (0.27% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on MUFG Intime India- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 8 Nov 2024
- Refunds initiated
- 8 Nov 2024
- Shares credited to demat
- 11 Nov 2024
- Listing
- 12 Nov 2024
Grey market premium (GMP)
- Current GMP
- ₹1
- +3.00%
- Estimated listing price
- ₹31
- Issue price ₹30
- Highest
- ₹3
- 2 Nov
- Lowest
- ₹0
- 4 Nov
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 6 Nov 2024 | ₹1 | +3.00% | ₹31 |
| 4 Nov 2024 | ₹0 | 0.00% | ₹30 |
| 2 Nov 2024 | ₹3 | +10.00% | ₹33 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB3.52x
- NII (HNI)1.93x
- Retail4.16x
- Employee3.75x
Financials
- P/E (pre-issue)
- 61.52
- P/E (post-issue)
- 61.52
- EPS (₹)
- 0.49
- RoNW
- 0.29%
- PAT Margin
- 11.83%
- Debt / Equity
- 0.15
- NAV (₹)
- 16.25
Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price.
| Period ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 10,388.01 | 10,664.20 | 10,590.48 | 10,096.28 |
| Total Income | 1,247.76 | 4,781.50 | 4,236.06 | 944.39 |
| Profit After Tax | 22.29 | 228.27 | 143.57 | -4.67 |
| NET Worth | 7,608.16 | 6,443.13 | 6,206.67 | 4,026.62 |
| Total Borrowing | 943.91 | 1,933.52 | 2,347.94 | 4,239.23 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Sagility India This IPO | ₹2,106.4 Cr | 61.52 | 0.29% | 11.83% | 3.2x | +3.53% |
| Akums Drugs & Pharmaceuticals Mainboard · listed 6 Aug 2024 | ₹1,856.74 Cr | 13580 | -0.57% | 0.02% | 63.44x | +6.77% |
| Indegene Mainboard · listed 13 May 2024 | ₹1,841.76 Cr | 33.53 | 18.23% | 12.62% | 70.3x | +44.91% |
| Inventurus Knowledge Solutions Mainboard · listed 19 Dec 2024 | ₹2,497.92 Cr | 54.66 | 32% | 20.38% | 52.68x | +42.96% |
| Symbiotec Pharmalab Mainboard · listed 1 Sep 2026 | ₹1,757 Cr | 56.81 | 9.48% | 12.60% | 71.26x | 0.00% |
| Entero Healthcare Solutions Mainboard · listed 16 Feb 2024 | ₹1,600 Cr | 129.75 | -1.86% | 4.69% | 1.56x | -2.33% |
| Sai Life Sciences Mainboard · listed 18 Dec 2024 | ₹3,042.62 Cr | 203.82 | 8.13% | 5.65% | 10.27x | +18.40% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
About Sagility India
Sagility India Limited was incorporated as Berkmeer India Private Limited at Bengaluru on 28 July 2021. It provides technology-enabled business solutions and services to clients in the US healthcare industry. It is a pure-play healthcare services provider. Its clients include payers, meaning US health insurance companies, and providers such as hospitals, physicians, and diagnostic and medical device companies. It also operates in other international markets such as the Philippines, Colombia and Jamaica. Its promoters are Sagility B.V. and Sagility Holdings B.V. The IPO was Rs 2,106.4 crore and was entirely an offer for sale by Sagility B.V., so the company received none of the money.
Strengths
- Total income rose from Rs 4,236.06 crore in FY2023 to Rs 4,781.50 crore in FY2024.
- Profit after tax rose from Rs 143.57 crore in FY2023 to Rs 228.27 crore in FY2024.
- Total borrowing fell from Rs 4,239.23 crore on 31 March 2022 to Rs 943.91 crore on 30 June 2024.
- It serves both US health insurers and providers, across 4 named countries of operation.
- Net worth was Rs 7,608.16 crore on 30 June 2024.
Risks
- The whole Rs 2,106.4 crore issue was offer for sale, so no money went to the company.
- The P/E was 61.52 at the upper band of Rs 30, based on EPS of Rs 0.49.
- Almost all clients are in the US healthcare market, so US policy changes and the dollar rate matter for its Rs 4,781.50 crore of income.
- Profit was only Rs 22.29 crore in the three months to 30 June 2024, and return on net worth was 0.29% as per the source.
- The promoter held 97.39% before the issue and 82.39% after it, as per the prospectus.
Promoters and shareholding
Sagility BV and Sagility Holdings BV
- Promoter holding, pre-issue
- 97.39%
- Promoter holding, post-issue
- 82.39%
Registrar, lead managers and documents
Lead managers
Documents
Sagility India IPO: common questions
1.When does the Sagility India IPO open and close?
The Sagility India IPO opens on 5 Nov 2024 and closes on 7 Nov 2024.
2.What is the price band of the Sagility India IPO?
The price band is ₹28 – ₹30 per share, with a lot size of 500 shares and a minimum investment of ₹15,000.
3.What is the size of the Sagility India IPO?
The issue size is ₹2,106.4 Cr (OFS only).
4.What is the GMP of the Sagility India IPO?
The last reported grey market premium is ₹1 per share as of 06 Nov 2024, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Sagility India IPO allotment?
The basis of allotment is expected on 8 Nov 2024. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.
6.When will the Sagility India IPO list?
The shares listed on 12 Nov 2024 on BSE, NSE.
7.Who is the lead manager of the Sagility India IPO?
The book running lead managers are ICICI Securities, Jefferies India Private Limited, IIFL Capital Services Limited, JP Morgan India Pvt. Ltd, and the registrar is MUFG Intime India Private Limited.
8.How can my company launch an IPO like Sagility India?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393